Edesa Biotech, Inc. EDSA
Set alert
2.57 USD -0.11 -4.10%
At close · Oct 30
2.58 +0.01 +0.39%
After hours · Oct 30, 4:00 PM ET
2.56 Day range 2.86
0.80 52-week range 18.28
- YTD
- +80.99%
- 1 year
- +37.43%
- Open
- 2.86
- Prev close
- 2.68
- Mkt cap
- 34.72M
- Vol
- 30.64K
- Avg vol
- 57.41K
- EPS
- -1.72
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.56
- High
- 2.86
- Forward P/E
- -0.89
- Beta
- 0.84
- Short ratio
- 0.76
- Inst. own
- 12.20%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 14, 2025
- 50-d avg
- 2.66
- 200-d avg
- 4.02
- 1y target
- 20.50
Financial health
Altman Z-Score
-7.86 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -1.9×
FY 2016 5y median -1.9× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.1×
FY 2016 5y median 1.8× FY 2025
P/FCF -1.9×
FY 2016 5y median -1.9× FY 2025
EV/EBITDA -0.5×
FY 2016 5y median -0.9× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -52.2%
FY 2016 5y median -52.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -57.7%
FY 2016 5y median -118.8% FY 2025
ROIC -63.5%
FY 2016 5y median -179.3% FY 2025
ROA -53.1%
FY 2016 5y median -94.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -12.8%
FY 2016 FY 2025
EPS (diluted) 34.2%
FY 2016 FY 2025
Free Cash Flow -49.7%
FY 2016 FY 2025
Financial Health
Current Ratio 10.7×
FY 2016 5y median 4.2× FY 2025
Quick Ratio 10.7×
FY 2016 5y median 4.2× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.5×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-09-30